slotkoers
Korea S.E.
00:00:00 26-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.020
KRW
|
+2,55%
|
|
+1,85%
|
+55,83%
|
Fiscaal tijdperk: december |
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
129.707
|
43.575
|
44.182
|
Bedrijfswaarde
1 |
99.272
|
9.146
|
25.899
|
K/w-verhouding
|
61,6
x
|
166
x
|
-13,8
x
|
Dividendrendement
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
9,28
x
|
2,93
x
|
3,2
x
|
Bedrijfswaarde/omzet
|
7,1
x
|
0,61
x
|
1,88
x
|
Bedrijfswaarde/EBITDA
|
35,6
x
|
27,6
x
|
-13,6
x
|
Bedrijfswaarde/FCF
|
-92.494.221
x
|
5.571.550
x
|
-1.812.584
x
|
FCF Yield
|
-0%
|
0%
|
-0%
|
Price to Book
|
3,86
x
|
1,44
x
|
1,51
x
|
Aantal aandelen (in duizenden)
|
21.836
|
21.153
|
22.798
|
Referentieprijs
2 |
5.940
|
2.060
|
1.938
|
Datum van publicatie
|
28/02/22
|
20/03/23
|
18/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
10.206
|
13.120
|
13.978
|
14.883
|
13.790
|
EBITDA
1 |
1.350
|
4.064
|
2.792
|
331
|
-1.906
|
Bedrijfsresultaat (EBIT)
1 |
850,9
|
3.531
|
2.091
|
-754,7
|
-3.465
|
Operationele Marge
|
8,34%
|
26,91%
|
14,96%
|
-5,07%
|
-25,12%
|
Resultaat voor belastingen (EBT)
1 |
872,8
|
4.591
|
2.170
|
76,56
|
-3.308
|
Nettowinst (verlies)
1 |
764,2
|
3.775
|
1.923
|
266,5
|
-2.970
|
Nettomarge
|
7,49%
|
28,77%
|
13,75%
|
1,79%
|
-21,54%
|
WPA
2 |
24.007
|
219,4
|
96,46
|
12,43
|
-140,4
|
Free Cash Flow
|
-
|
4.758
|
-1.073
|
1.642
|
-14.288
|
FCF-marge
|
-
|
36,27%
|
-7,68%
|
11,03%
|
-103,61%
|
Kasstroomconversie (ebitda)
|
-
|
117,08%
|
-
|
496,02%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
126,06%
|
-
|
615,99%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/06/20
|
1/04/21
|
28/02/22
|
20/03/23
|
18/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
9.079
|
14.356
|
30.435
|
34.429
|
18.283
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
4.758
|
-1.073
|
1.642
|
-14.288
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
27,8%
|
7,13%
|
-0,17%
|
-9,48%
|
ROA (netto-inkomsten/totale activa)
|
-
|
11,9%
|
4,42%
|
-1,11%
|
-4,79%
|
Totale activa
1 |
-
|
31.807
|
43.482
|
-23.915
|
62.076
|
Nettoactief per aandeel
2 |
348.200
|
834,0
|
1.538
|
1.434
|
1.284
|
Cashflow per aandeel
2 |
108.316
|
498,0
|
241,0
|
146,0
|
159,0
|
Capex
1 |
62,1
|
75,9
|
1.074
|
1.417
|
12.435
|
Capex/omzet
|
0,61%
|
0,58%
|
7,68%
|
9,52%
|
90,18%
|
Datum van publicatie
|
11/06/20
|
1/04/21
|
28/02/22
|
20/03/23
|
18/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +55,83% | 44,78 mln. | | +29,78% | 52,73 mld. | | +37,49% | 39 mld. | | -9,21% | 38,52 mld. | | +28,44% | 30,38 mld. | | -12,26% | 26,39 mld. | | +11,44% | 26,08 mld. | | +45,56% | 14,15 mld. | | +33,03% | 12,6 mld. | | -5,46% | 11,51 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|